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This protocol outlines a reliable and versatile approach to isolate stromal
vascular fraction cells from different adipose tissues across human and mouse
species. A number of downstream applications can then be performed to gain
an appreciation of the functional activity of unique adipose tissue-resident cell
populations.
For complete details on the use and execution of this protocol, please refer to
Macdougall et al. (2018).
BEFORE YOU BEGIN
This protocol outlines a highly consistent and versatile method of isolating stromal vascular cell pop-
ulations from human andmouse adipose tissues. Compared with previously published protocols, we
illustrate its applicability across species and different types of adipose tissue (visceral and subcu-
taneous) and highlight critical points such as the importance of measuring collagenase enzymatic
activity when adding to the adipose tissue digestion suspension. Furthermore, given the exhaus-
tively detailed nature of the protocol framework, we feel this makes it highly reproducible, easy-
to-follow with clear examples of the benefits, potential pitfalls, and relevant troubleshooting steps.
Before attempting this protocol, ensure all reagents and buffers are made up to a suitable volume
(see materials and equipment). To avoid unnecessary waiting during steps that are reliant on enzy-
matic activity, we recommend turning on your shaker-incubator and setting the temperature to 37C
beforehand.
For the duration of this protocol (with the exception of the incubation step during digestion), keep all
reagents, buffers, and samples on ice. This is crucial for preserving cell yield. It is also important if you
are trying to isolate macrophage populations (which can stick to plasticware). Keeping samples cold
can minimize this.
The use of animals and human tissue for research requires ethical approval. Therefore, ethical
approval from the relevant institutional or other regulatory body must be obtained prior to the
use of animal or human tissue for research purposes.
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Harvesting adipose tissue - mouse (epididymal fat pad)
Timing: [30–45 min]
1. Sacrifice mouse using an appropriate method as per local animal license regulations.
Note: Typically, males will have more abdominal visceral adipose tissue than females. Like-
wise, mice on western or high fat diets will yield much more visceral adipose tissue than those
on a normal chow diet.
2. Spray 70% ethanol over the fur in order to sterilize the external surface.
3. Placing the mouse on its back in the supine position, and using forceps and scissors, make a
lateral incision across the abdomen just beneath the diaphragm. From the midpoint of the first
incision make a further cut along the midline towards the rectum.
4. Dissect the epididymal fat pads from both sides of the mouse, taking care to avoid the testes or
ovaries, and any lymph nodes.
5. Transfer the adipose tissue directly into ice coldWash/Digestion buffer and proceed to digestion
protocol.
Pause point:While it is best to proceed directly to the digestion protocol, you can leave the
adipose tissue in the fridge at this point for 1–12 h, which is better than pausing during the
digestion protocol.
Note: Pausing here will result in decreased cell yield.
Obtaining adipose tissue – human (e.g., epicardial, mediastinal, and subcutaneous adipose
tissue)
Timing: [20–30 min]
6. Prepare a 50 mL Falcon tube containing 20 mL of Wash/Digestion buffer ready for the transfer of
human adipose tissue samples acquired from surgical procedures.
7. Immediately transfer human adipose tissue samples to ice cold Wash/Digestion buffer and keep
on ice. Minimum adipose tissue recommended for the protocol is 0.15 g.
Note: Depending on the type of adipose tissue collected (e.g., subcutaneous, visceral) resid-
ual blood may be present. Ensure samples are thoroughly washed with Wash/Digestion
buffer. The wash steps involve serial (two) immersions of the tissues in fresh Wash/Digestion
buffer to remove residual blood.
8. Using sterile forceps and scissors, carefully dissect out any additional non-adipose tissue (e.g.,
connective tissue, cauterized tissue) (Figure 1A).
9. Proceed to digestion protocol.
Pause point:While it is best to proceed directly to the digestion protocol, you can leave the
adipose tissue in the fridge at this point for 1–12 h, which is better than pausing during the
digestion protocol.
Note: Pausing here will result in decreased cell yield.
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KEY RESOURCES TABLE
REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Anti-human CCR7 BioLegend Cat# 353216; RRID: AB_10916386
Anti-human CD19 BioLegend Cat# 302228; RRID: AB_893272
(Continued on next page)
Figure 1. Examples of how samples look before and after different steps of the adipose tissue digestion protocol
(A) Ensure adipose tissue samples are thoroughly washed and processed to remove residual blood and non-adipose
tissue (e.g., connective tissue, cauterized tissue).
(B) If there are still lumps of adipose tissue visible within the sample (Left) after step 3 of the digestion protocol, then
return samples to the shaker-incubator until they form a homogeneous mixture (Right).
(C) If samples look partially digested (Left) after step 5, with adipose tissue still visible, then carry out the additional re-
digestion step before proceeding to step 6. If samples look completely digested (Right), with only lipid droplets
visible, then proceed to step 6 of the adipose tissue digestion protocol.
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REAGENT or RESOURCE SOURCE IDENTIFIER
Anti-human CD45 BioLegend Cat# 304048; RRID: AB_2563129
Anti-human CD3 BioLegend Cat# 300318;RRID: AB_314054
Anti-human CD4 BioLegend Cat# 357410; RRID: AB_2565662
Anti-human CD8a BioLegend Cat# 300920; RRID: AB_528885
Anti-human CD45RO BioLegend Cat# 304224; RRID: AB_2563817
Anti-human CD14 BioLegend Cat# 325608; RRID: AB_830681
Anti-human CD16 BioLegend Cat# 302026; RRID: AB_2278418
Anti-human CD206 BioLegend Cat# 321126; RRID: AB_2563839
Anti-human CD141 BioLegend Cat# 344110; RRID: AB_2561623
Anti-human Clec9A BioLegend Cat# 353804; RRID: AB_10965546
Anti-human CD1c BioLegend Cat# 331520; RRID: AB_10644008
Anti-mouse CD45 BioLegend Cat# 103146; RRID: AB_2564003
Anti-mouse CD11c BioLegend Cat# 117317; RRID: AB_493569
Anti-mouse CD11b Thermo Fisher Scientific Cat# 47-0112-82; RRID: AB_1603193
Anti-mouse MHCII BioLegend Cat# 107622; RRID: AB_493727
Anti-mouse CD8a Thermo Fisher Scientific Cat# 17-0081-82; RRID: AB_469335
Chemicals, peptides, and recombinant proteins
Deoxyribonuclease I from bovine pancreas Sigma Cat# D4527
Collagenase from Clostridium histolyticum
(type II)
Sigma Cat# C6885
Fetal bovine serum SeraLab Cat# EU-000-F
Dulbecco’s phosphate buffered saline pH 7.2
(without CaCl2 and MgCl2)
Sigma Cat# D8537-500ML
EDTA solution Sigma Cat# E7889-100ML
NH4Cl Sigma Cat# A9434-1KG
KHCO3 Sigma Cat# 237205-100g
Na3EDTA Sigma Cat# ED3SS-1KG
TES Sigma Cat# T1375-100G
CaCl2 Sigma Cat# C7902-500G
NaCl Sigma Cat# S7653-1KG
Critical commercial assays
Dead Cell Removal Kit Miltenyi Biotec Cat# 130-090-101
CD11c MicroBeads UltraPure, mouse Miltenyi Biotec Cat# 130-125-835
Other
7 mL Bijou container Thermo Fisher Scientific Cat# 129A
50 mL Falcon tubes Corning Cat# 430829
100 mm Cell strainer Fisher Cat# 11517532
70 mm Cell strainer Greiner Cat# 542070
V-Bottom 96-well plate Sarstedt Cat# 83.3926.500
LIVE/DEAD Fixable Aqua Stain Invitrogen Cat# L34966
Shaker-incubator (225 rpm, 37C) N/A N/A
Refrigerated centrifuge (800 3 g, 4C) N/A N/A
DNase
Reagent Final Concentration (mM or mM) Amount
Deoxyribonuclease I from Bovine Pancreas 11,100 U/mL Varies by batch
NaCl 150 mM 8.766 mg
ddH2O n/a 1 mL
Total n/a 1 mL
Store at 20C for up to 1 year.
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STEP-BY-STEP METHOD DETAILS
Processing and digesting the adipose tissue
Timing: [1–2 h]
During this step, the adipose tissue is processed and digested. This isolates the stromal vascular
fraction cells from the extracellular matrix whilst ensuring their viability.
1. Weigh the adipose tissue and add 2 mL of ice-cold Wash/Digestion buffer per gram of sample.
Note: If samples are <1g, add 2 mL of ice-cold Wash/Digestion and continue with all steps.
Note: If the adipose tissue weighs up to 2 g then we suggest using 7 mL bijou tubes. However,
if the samples exceed 2 g then use larger tubes (e.g., 15 mL tubes) or split the sample into two
smaller tubes and weigh each separately.
Collagenase II
Reagent Final Concentration (mM or mM) Amount
Collagenase from Clostridium Histolyticum (Type II) 14,220 U/mL Varies by batch
TES 50 mM 572.5 mg
CaCl2 360 mM 2.645 mg
ddH2O n/a 50 mL
Total n/a 50 mL
Store at 20C for up to 1 year. Use 1M NaOH to adjust to pH of 7.4.
Wash/Digestion Buffer
Reagent Final Concentration (mM or mM) Amount
Fetal Bovine Serum 2% 10 mL
Dulbecco’s Phosphate Buffered Saline pH 7.2 (without CaCl2 and
MgCl2)
13 490 mL
Total n/a 500 mL
Store at 4C for up to 3 months.
MACS Buffer
Reagent Final Concentration (mM or mM) Amount
Fetal Bovine Serum 2% 10 mL
EDTA (0.5 M) 2 mM 2 mL
Dulbecco’s Phosphate Buffered Saline pH 7.2 (without CaCl2 and
MgCl2)
13 488 mL
Total n/a 500 mL
Store at 4C for up to 3 months.
ACK Lysis Buffer (13)
Reagent Final Concentration (mM or mM) Amount
NH4Cl 150 mM 8.29 g
KHCO3 10 mM 1.0 g
Na3EDTA 0.1 mM 37.2 mg
ddH2O n/a 1000 mL
Total n/a 1000 mL
Store at 20C–25C for 6 months.
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2. Using sterile scissors, mince the adipose tissue and add 200 mL Collagenase II (2844 U) and 2.5 mL
DNase (27.75 U) per mL of Wash/Digestion buffer.
CRITICAL: Always check LOT number and corresponding enzymatic activity in Units per
mg when making up the Collagenase II and DNase stock solutions, as this will vary. As a
result, it is not practical to state the enzyme concentrations in mg/mL as we must stan-
dardise to U/mL.
CRITICAL: Ensure at this point that all the adipose tissue is floating. Any tissue
present sinking to the bottom of the tube is likely to be non-adipose tissue and should
be removed.
Note: Store the Collagenase II and DNase enzyme stock solutions in small aliquots to mini-
mise the effect of repeated freeze/thaw cycles, which will decrease the enzymatic activity.
3. Place samples in a shaker-incubator at 37C and 225 rpm for 25–30 min.
Note: Digested samples should look homogeneous and pinkish white in colour, larger sam-
ples can take slightly longer than smaller samples (Figure 1B).
4. Transfer the samples through a 100 mm cell sieve into a 50 mL tube pre-washed with ice cold
Wash/Digestion buffer. Then top up the Falcon tube to 30 mL with Wash/Digestion buffer.
Note: Ensure you rinse the sample tube used for digestion with Wash/Digestion buffer to re-
move any remaining sample and strain through the same 100 mm cell sieve.
5. Centrifuge samples at 800 3 g for 10 min at 4C.
CRITICAL: After centrifugation, open the tubes and check that the floating portion of the
sample is composed of transparent lipid droplets. If you can see a white layer of adipose
tissue floating, then this top layer will need removing with a Pasteur pipette and re-diges-
tion (Figure 1C). Re-digest in 2 mL Wash/Digestion buffer, with half the original collage-
nase volume used i.e., 200 mL Collagenase II in 2 mL Wash/Digestion buffer, with 5 mL
DNase for 10 min (as in step 3). This will ensure you obtain all the stromal cells possible,
particularly macrophages, from within each sample.
6. Discard supernatant and the remaining pellet contains the stromal vascular fraction cells.
Note: Proceed directly to wash step 8 if you will use bead enrichment (recommended), other-
wise carry out red blood cell lysis described in step 7.
7. Optional: Resuspend pellets in 500 ml of red blood cell lysis buffer (ACK Lysis Buffer) for about
1 min.
8. Top up with ice cold Wash/Digestion buffer and transfer the samples through a 70 mm cell sieve
into a 50 mL tube pre-washed with Wash/Digestion buffer. Then fill the tube to the top with
Wash/Digestion buffer.
9. Centrifuge samples at 800 3 g for 10 min at 4C.
10. Discard supernatant and the remaining pellet contains the stromal vascular fraction cells.
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This step enriches cells from the population of interest within a sample and as a result can change for
any given experiment. We recommend this step is completed to reduce time required for flow cy-
tometry assisted cell sorting. In this example we enrich live cells from the stromal vascular fraction
of mouse adipose tissue followed by positive enrichment of CD11c + cells to increase the relative
proportion of conventional dendritic cells (cDCs) within our samples (Figure 2A).
11. Re-suspend the cell pellet in ice cold 13 binding buffer (Miltenyi Biotec) containing Dead Cell
Removal MicroBeads (Miltenyi Biotec) at 200 mL per 107 cells and follow manufacturer’s instruc-
tions.
Note: Transferring the sample into fresh tubes at this stage prevents excess lipids which are
stuck to the inside of the previous tube from affecting the sample.
Note: We use twice the concentration recommended by the manufacturer for dead cell
removal, as there is a higher abundance of dead cells compared to cDCs (our cells of interest).
Figure 2. Bead enrichment and flow cytometry gating strategy for isolation of conventional dendritic cell subsets
from mouse adipose tissue
(A) The beneficial effects of magnetic bead enrichment (dead cell removal and CD11c+ enrichment) on live cells and
conventional dendritic cell populations within a sample.
(B) An example flow cytometry gating strategy for the isolation of conventional dendritic cell subsets (cDC1 and
cDC2). Note that stromal vascular fractions taken frommouse adipose tissue were pooled (to increase yield) and cDCs
expressing a Zbtb46-GFP reporter are shown in this example.
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12. The effluent from the magnetic column is your live cell enriched population. Top-up these tubes
with MACs buffer and centrifuge at 350 3 g for 5 min at 4C.
13. Discard supernatant and resuspend pellet in ice cold MACs buffer containing CD11c MicroBe-
ads (Miltenyi Biotec) following manufacturer’s instructions. Depending on adipose tissue site
and metabolic status, a total of 105 to 106 CD45+ cells/g of fat are expected.
14. The sample you are left with is a single cell suspension enriched for live cells and CD11c+ cells.
Proceed to next step.
Optional: You can change these enrichment steps to suit your experiment. However, you may
need to optimise bead concentrations.
Extracellular staining and cell sorting
During this step, you isolate a particular cell population of interest from the stromal vascular fraction
by flow cytometry assisted cell sorting. Alternatively, if you do not need to obtain pure cell suspen-
sions, you can add experimental readout markers and analyze the cells present in the stromal
vascular fraction directly by regular flow cytometry.
15. Take single cell suspensions and centrifuge at 350 3 g for 5 min at 4C.
16. Resuspend cell pellets in 75 mL of PBS containing diluted fluorescently conjugated extracellular
antibody markers following manufacturer’s instructions.
Note: See Figures 2B and 3 for examples of immune cell populations isolated from human and
mouse adipose tissues and their gating strategies.
17. Incubate cells in the dark at 4C for 18 min.
18. Add ice cold PBS and centrifuge at 350 3 g for 5 min at 4C.
19. Resuspend pellet in ice cold MACs buffer as a wash and centrifuge at 350 3 g for 5 min at
4C.
20. Resuspend pellet in a small volume of MACs buffer and proceed to flow cytometry assisted cell
sorting.
Note: We usually resuspend cells taken from one mouse in around 500 mL for cell sorting on
either a BD FACS Aria II or a BD FACS fusion cell sorter.
EXPECTED OUTCOMES
Upon the completion of this protocol, viable single cell suspensions containing the stromal vascular
fraction of adipose tissue should be obtained. With further processing, pure suspensions of immune
cells (e.g., macrophages, T cells, B cells, and dendritic cell subsets) in addition to other stromal pop-
ulations such as pre-adipocytes, endothelial cells, fibroblasts, and mesenchymal progenitor/stem
cells can be acquired.
From these single cell suspensions, there are several potential downstream applications (Macdou-
gall et al., 2018). For instance, selective cell populations could be cultured for in vitro assays, flow
cytometry (Figure 3), RNA-sequencing (e.g., sc-RNAseq), total RNA extraction for real-time PCR,
or submitted for proteomic or metabolomic analyses. Additionally, cell samples can be lysed to eval-
uate protein expression through western blot analysis.
The consistent nature of this protocol makes it uniquely versatile and as a result, it can better facil-
itate comparison between species and anatomically distinct adipose depots in contrast to other pro-
tocols where different digestion methods are routinely required.
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LIMITATIONS
Adipose depots can harbor unique cellular profiles based on their anatomical location and factors
such as adiposity state (as alluded to earlier mice on high fat diets tend to yieldmore visceral adipose
tissue). These differences can be readily observed in the stromal vascular fraction when subcutane-
ous and visceral adipose tissues are analyzed comparatively (Peinado et al., 2010)(Silva et al., 2017).
Under normal homeostatic conditions, these stromal cells help maintain the functional activity of ad-
ipose tissue from its metabolic duties as a site for energy storage, to its role as an endocrine organ for
various biologically active compounds (Macdougall et al., 2018)(Mahlakõiv et al., 2019). Therefore,
depending on the type of adipose tissue used for this protocol, the abundance of different stromal
cell populations can vary. This should be taken into consideration when acquiring samples as you
may need to digest more adipose tissue in order to obtain and sufficiently define rarer cell
populations.
Figure 3. Example flow cytometry gating strategy for quantifying immune cell populations from digested adipose tissues








Adipose tissue is partially digested (Figures 1B and 1C).
Potential solution
If you find that you frequently only achieve partial digestions, try to reconsider the tubes you
are using. The best sized tubes to perform the digest in are those which are only around half
full; this allows for optimal mixing and facilitates physical movement of the sample in the
shaker-incubator.
Problem 2
Low cell viability after isolating stromal vascular fraction.
Potential solution
It is possible that you may observe a larger number of dead cells after digestion (particularly if pro-
cessing mouse tissue). If this becomes an issue, it is important that you check your collagenase lot
number and verify that the activity (measured in units) is comparable to other batches used. It is
also important that you check the conditions used for digestion e.g., incubation periods greater
than 30 min will ultimately reduce cell viability.
Problem 3
No visible digestion has taken place.
Potential solution
If no digestion has taken place after greater incubation times (e.g., 30min) it is possible that either no
enzyme was added, or the collagenase II used has impaired enzymatic activity. Ensure all enzymes
are stored correctly and try to avoid repeated freeze thaw cycles.
Problem 4
Small white lumps are floating in the digested samples.
Potential solution
If you accidentally include any non-adipose tissue with the sample you are digesting (such as the
testes or ovarian tissue in mice), your sample can become contaminated and as a result should be
removed from your experiment and repeated with freshly obtained adipose tissue. In order to pre-
vent this from occurring, ensure that all of the tissue in your tube (prior to adding digestion enzymes),
is floating (Figure 4A). If there is white tissue sinking within your sample, then it is not adipose tissue
and should be removed before proceeding to the next stage.
Problem 5
More cells are obtained unexpectedly when cell sorting or analyzing via flow cytometry
(Figure 4B).
Potential solution
It is possible that during the dissection there was a lymph node amongst the adipose tissue in the
sample. This would mean that your sample contains more immune cells than it should. In this event
you will need to disregard the data you obtain, as the cells in the sample will be predominantly
derived from the lymph node rather than the adipose tissue. To avoid this, prior to adding the diges-
tion enzymes, inspect the samples and ensure that any areas of the adipose sample which appear
slightly darker and vascularized are indeed adipose tissue. A quick way to test this is to cut the darker
section out and test whether it floats (Figure 4A). If it sinks, then it is not adipose tissue.
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Further information and requests for resources and reagents should be directed to and will be ful-
filled by the lead contact, Dr M. Paula Longhi (m.longhi@qmul.ac.uk).
Materials availability
This study did not generate new unique reagents.
Data and code availability
This study did not generate any unique dataset or code.
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Figure 4. Samples contaminated with different non-adipose tissues can affect experimental data
(A) Tissue samples that sink in Wash/Digestion buffer are most likely not adipose tissue. When acquiring adipose
tissue (AT) from mice, if testes (middle) or lymph nodes (LN) (right) are accidentally acquired, ensure they are removed
before digestion.
(B) Tissue contaminants can distort different cell populations. As shown via flow cytometry analysis, when lymph nodes
from a mouse are present during digestion, samples have increased CD45+ cells. This can compromise studies
investigating T cell (CD45+ CD3+) abundance (right).
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